Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis-Reference-Cited by-同舟云学术

Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis

Published:2021-08 Issue: Volume:163 Page:105868
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Li Xue,Qi Hui,Jin Fei,Yao Bu-Fan,Wu Yue-E,Qi Yu-Jie,Kou Chen,Wu Xi-Rong,Luo Xiao-Jing,Shen Yan-Hua,Zheng Xu,Wang Yong-Hong,Xu Fang,Jiao Wei-Wei,Li Jie-Qiong,Xiao Jing,Dong Yi-Ning,Du Bin,Shi Hai-Yan,Xu Bao-Ping,Shen A-Dong,Zhao Wei

Funder

Shandong University

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development;Abdul-Aziz;Semin. Respir. Crit. Care Med.,2015

2. Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology;Barker;Adv. Drug. Deliv. Rev.,2014

3. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins;Craig;Diagn. Microbiol. Infect. Dis.,1995

4. Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa;Crandon;Antimicrob. Agents Chemother.,2010

5. Comparison of ex-vivo serum bactericidal activity of cefepime, ceftazidime and cloxacillin against Staphylococcus aureus;Dan;Diagn. Microbiol. Infect. Dis.,1999

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose optimization of β-lactam antibiotics in children: from population pharmacokinetics to individualized therapy;Expert Opinion on Drug Metabolism & Toxicology;2024-08

2. Optimal use of β-lactams in neonates: machine learning-based clinical decision support system;eBioMedicine;2024-07

3. The Impact of Spironolactone Co-administration on Cyclosporin Initial Dosage Optimization for Pediatric Refractory Nephrotic Syndrome;Current Pharmaceutical Design;2024-05

4. Development and validation of a UPLC-PDA method for quantifying ceftazidime in dried blood spots;Journal of Pharmaceutical and Biomedical Analysis;2024-02

5. Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Term Asphyxiated Neonates during Controlled Therapeutic Hypothermia;Antimicrobial Agents and Chemotherapy;2023-05-17